MediWound: Overview of Fourth Quarter Financial Results

MediWound Reports Fourth Quarter Financial Results

MediWound Ltd., headquartered in Yavne, Israel, announced a net loss of $7.2 million for the fourth quarter.

The company recorded a quarterly loss of 56 cents per share.

These figures were better than analysts had anticipated, as a consensus of six analysts polled by Zacks Investment Research had projected a loss of 65 cents per share.

The firm, which specializes in developing therapies for burns and chronic wounds, generated $1.9 million in revenue during the quarter. This amount was below the $2.1 million revenue expected by four analysts surveyed by Zacks.

For the full year, MediWound reported a total loss of $23.9 million, translating to $2.10 per share, with annual revenue reaching $17 million.

Looking ahead, the company forecasts its revenue for the upcoming year to fall between $24 million and $26 million.